Results 201 to 210 of about 279,139 (356)

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy   +15 more
wiley   +1 more source

Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications. [PDF]

open access: yesMed Sci (Basel)
Karakasis P   +7 more
europepmc   +1 more source

Noninvasive cardiac radiation for ablation of ventricular tachycardia [PDF]

open access: yes, 2017
Cooper, Daniel   +12 more
core   +2 more sources

Cardiac Purkinje fibers and arrhythmias; The GK Moe Award Lecture 2015 [PDF]

open access: bronze, 2016
Penelope A. Boyden   +2 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Psychological Interventions for Reducing Distress in Patients with Cardiac Arrhythmias. [PDF]

open access: yesCurr Cardiol Rep
Särnholm J   +4 more
europepmc   +1 more source

Cardiac arrhythmias in patients with Danon disease [PDF]

open access: bronze, 2016
Torsten Konrad   +8 more
openalex   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Role of ruxolitinib in preventing cardiac arrhythmias: A pooled analysis of clinical studies in hematology. [PDF]

open access: yesInt J Cardiol Heart Vasc
Zaoli S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy